These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9383894)

  • 1. Recombinant allergens; basic and practical considerations.
    Breiteneder H; Hoffmann-Sommergruber K; Vanek-Krebitz M; Kraft D; Scheiner O
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):80-6. PubMed ID: 9383894
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natural allergens and recombinant allergens].
    Deviller P
    Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-tailored recombinant allergen products--mission impossible?
    Cromwell O; Matricardi PM; Fiebig H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():210-7; discussion 217-8. PubMed ID: 20799463
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural allergen extracts: is there a future in allergy diagnosis and therapy?
    Lehrer SB; Reese G
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):73-8; discussion 79. PubMed ID: 9383893
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergen extract standardization: reality, myth, or dream?
    Dolen WK
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):81-2. PubMed ID: 7648386
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant and modified allergens: the U.S. perspective.
    Rabin RL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):191-3; discussion 193-4. PubMed ID: 17393739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standards for practical allergen-specific immunotherapy.
    Alvarez-Cuesta E; Bousquet J; Canonica GW; Durham SR; Malling HJ; Valovirta E;
    Allergy; 2006; 61 Suppl 82():1-20. PubMed ID: 16930249
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-based methods for standardization of allergoids and recombinant hypoallergens.
    Fiebig H; Kahlert H; Weber B; Suck R; Nandy A; Cromwell O
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():71-82; discussion 82-3. PubMed ID: 20799447
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant allergens for specific immunotherapy.
    Valenta R; Vrtala S
    Allergy; 1999; 54 Suppl 56():43-4. PubMed ID: 10532305
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recombinant allergens and their potential in allergologic diagnosis].
    Crameri R; Blaser K; Menz G
    Pneumologie; 1996 Jun; 50(6):387-93. PubMed ID: 8766370
    [No Abstract]   [Full Text] [Related]  

  • 16. Current problems of regulation of allergenic extracts in Germany.
    Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):123-6. PubMed ID: 9383900
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical testing of recombinant allergens of the mold Alternaria alternata.
    Unger A; Stöger P; Simon-Nobbe B; Susani M; Crameri R; Ebner C; Hintner H; Breitenbach M
    Int Arch Allergy Immunol; 1999; 118(2-4):220-1. PubMed ID: 10224387
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant house dust mite allergens.
    Thomas WR; Smith W; Hales BJ; Carter MD; Bennett BJ; Shen HD; Tovey ER; Chua KY
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):87-94; discussion 94-6. PubMed ID: 9383895
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D
    Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials with recombinant allergens--a regulatory perspective.
    Elferink AF
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():266-7; discussion 267-9. PubMed ID: 20799470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.